nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Degarelix—Diabetes mellitus—Doxorubicin—sarcoma	0.00249	0.00249	CcSEcCtD
Degarelix—Nervous system disorder—Vincristine—sarcoma	0.00248	0.00248	CcSEcCtD
Degarelix—Decreased appetite—Thiotepa—sarcoma	0.00248	0.00248	CcSEcCtD
Degarelix—Menopausal symptoms—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Degarelix—Anaphylactic shock—Mitoxantrone—sarcoma	0.00247	0.00247	CcSEcCtD
Degarelix—Gastrointestinal disorder—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Degarelix—Decreased appetite—Dactinomycin—sarcoma	0.00246	0.00246	CcSEcCtD
Degarelix—Fatigue—Thiotepa—sarcoma	0.00246	0.00246	CcSEcCtD
Degarelix—Renal impairment—Epirubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Degarelix—Hyperhidrosis—Vincristine—sarcoma	0.00245	0.00245	CcSEcCtD
Degarelix—Fatigue—Dactinomycin—sarcoma	0.00244	0.00244	CcSEcCtD
Degarelix—Pain—Thiotepa—sarcoma	0.00244	0.00244	CcSEcCtD
Degarelix—Constipation—Thiotepa—sarcoma	0.00244	0.00244	CcSEcCtD
Degarelix—Back pain—Etoposide—sarcoma	0.00243	0.00243	CcSEcCtD
Degarelix—Pain—Dactinomycin—sarcoma	0.00242	0.00242	CcSEcCtD
Degarelix—Muscle spasms—Etoposide—sarcoma	0.00242	0.00242	CcSEcCtD
Degarelix—Cardiac failure—Epirubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Degarelix—Skin disorder—Mitoxantrone—sarcoma	0.00239	0.00239	CcSEcCtD
Degarelix—Hyperhidrosis—Mitoxantrone—sarcoma	0.00238	0.00238	CcSEcCtD
Degarelix—Hypotension—Vincristine—sarcoma	0.00237	0.00237	CcSEcCtD
Degarelix—Feeling abnormal—Thiotepa—sarcoma	0.00235	0.00235	CcSEcCtD
Degarelix—Feeling abnormal—Dactinomycin—sarcoma	0.00233	0.00233	CcSEcCtD
Degarelix—Gastrointestinal pain—Thiotepa—sarcoma	0.00233	0.00233	CcSEcCtD
Degarelix—Ill-defined disorder—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Degarelix—Anaemia—Etoposide—sarcoma	0.00232	0.00232	CcSEcCtD
Degarelix—Gastrointestinal pain—Dactinomycin—sarcoma	0.00232	0.00232	CcSEcCtD
Degarelix—Hot flush—Doxorubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Vincristine—sarcoma	0.00231	0.00231	CcSEcCtD
Degarelix—Hypotension—Mitoxantrone—sarcoma	0.0023	0.0023	CcSEcCtD
Degarelix—Menopausal symptoms—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Degarelix—Insomnia—Vincristine—sarcoma	0.00229	0.00229	CcSEcCtD
Degarelix—Renal impairment—Doxorubicin—sarcoma	0.00227	0.00227	CcSEcCtD
Degarelix—Urticaria—Thiotepa—sarcoma	0.00227	0.00227	CcSEcCtD
Degarelix—Malaise—Etoposide—sarcoma	0.00227	0.00227	CcSEcCtD
Degarelix—Abdominal pain—Thiotepa—sarcoma	0.00226	0.00226	CcSEcCtD
Degarelix—Body temperature increased—Thiotepa—sarcoma	0.00226	0.00226	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00225	0.00225	CcSEcCtD
Degarelix—Abdominal pain—Dactinomycin—sarcoma	0.00224	0.00224	CcSEcCtD
Degarelix—Body temperature increased—Dactinomycin—sarcoma	0.00224	0.00224	CcSEcCtD
Degarelix—Cardiac failure—Doxorubicin—sarcoma	0.00222	0.00222	CcSEcCtD
Degarelix—Decreased appetite—Vincristine—sarcoma	0.0022	0.0022	CcSEcCtD
Degarelix—Dyspnoea—Mitoxantrone—sarcoma	0.0022	0.0022	CcSEcCtD
Degarelix—Gastrointestinal disorder—Vincristine—sarcoma	0.00219	0.00219	CcSEcCtD
Degarelix—Fatigue—Vincristine—sarcoma	0.00218	0.00218	CcSEcCtD
Degarelix—Hypertension—Etoposide—sarcoma	0.00217	0.00217	CcSEcCtD
Degarelix—Pain—Vincristine—sarcoma	0.00216	0.00216	CcSEcCtD
Degarelix—Constipation—Vincristine—sarcoma	0.00216	0.00216	CcSEcCtD
Degarelix—Decreased appetite—Mitoxantrone—sarcoma	0.00214	0.00214	CcSEcCtD
Degarelix—Fatigue—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00212	0.00212	CcSEcCtD
Degarelix—Discomfort—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Degarelix—Breast disorder—Epirubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Degarelix—Pain—Mitoxantrone—sarcoma	0.00211	0.00211	CcSEcCtD
Degarelix—Constipation—Mitoxantrone—sarcoma	0.00211	0.00211	CcSEcCtD
Degarelix—Hypersensitivity—Thiotepa—sarcoma	0.0021	0.0021	CcSEcCtD
Degarelix—Hypersensitivity—Dactinomycin—sarcoma	0.00209	0.00209	CcSEcCtD
Degarelix—Gastrointestinal pain—Vincristine—sarcoma	0.00207	0.00207	CcSEcCtD
Degarelix—Muscular weakness—Epirubicin—sarcoma	0.00206	0.00206	CcSEcCtD
Degarelix—Anaphylactic shock—Etoposide—sarcoma	0.00205	0.00205	CcSEcCtD
Degarelix—Asthenia—Thiotepa—sarcoma	0.00205	0.00205	CcSEcCtD
Degarelix—Asthenia—Dactinomycin—sarcoma	0.00203	0.00203	CcSEcCtD
Degarelix—Feeling abnormal—Mitoxantrone—sarcoma	0.00203	0.00203	CcSEcCtD
Degarelix—Pruritus—Thiotepa—sarcoma	0.00202	0.00202	CcSEcCtD
Degarelix—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00202	0.00202	CcSEcCtD
Degarelix—Abdominal pain—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Degarelix—Body temperature increased—Vincristine—sarcoma	0.002	0.002	CcSEcCtD
Degarelix—Skin disorder—Etoposide—sarcoma	0.00199	0.00199	CcSEcCtD
Degarelix—Hyperhidrosis—Etoposide—sarcoma	0.00198	0.00198	CcSEcCtD
Degarelix—Urticaria—Mitoxantrone—sarcoma	0.00196	0.00196	CcSEcCtD
Degarelix—Breast disorder—Doxorubicin—sarcoma	0.00196	0.00196	CcSEcCtD
Degarelix—Diarrhoea—Thiotepa—sarcoma	0.00195	0.00195	CcSEcCtD
Degarelix—Abdominal pain—Mitoxantrone—sarcoma	0.00195	0.00195	CcSEcCtD
Degarelix—Body temperature increased—Mitoxantrone—sarcoma	0.00195	0.00195	CcSEcCtD
Degarelix—Diarrhoea—Dactinomycin—sarcoma	0.00194	0.00194	CcSEcCtD
Degarelix—Hypotension—Etoposide—sarcoma	0.00192	0.00192	CcSEcCtD
Degarelix—Muscular weakness—Doxorubicin—sarcoma	0.00191	0.00191	CcSEcCtD
Degarelix—Dysuria—Epirubicin—sarcoma	0.00189	0.00189	CcSEcCtD
Degarelix—Dizziness—Thiotepa—sarcoma	0.00189	0.00189	CcSEcCtD
Degarelix—Pollakiuria—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Degarelix—Hypersensitivity—Vincristine—sarcoma	0.00186	0.00186	CcSEcCtD
Degarelix—Weight increased—Epirubicin—sarcoma	0.00184	0.00184	CcSEcCtD
Degarelix—Weight decreased—Epirubicin—sarcoma	0.00183	0.00183	CcSEcCtD
Degarelix—Dyspnoea—Etoposide—sarcoma	0.00183	0.00183	CcSEcCtD
Degarelix—Hyperglycaemia—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Degarelix—Hypersensitivity—Mitoxantrone—sarcoma	0.00182	0.00182	CcSEcCtD
Degarelix—Asthenia—Vincristine—sarcoma	0.00182	0.00182	CcSEcCtD
Degarelix—Vomiting—Thiotepa—sarcoma	0.00181	0.00181	CcSEcCtD
Degarelix—Vomiting—Dactinomycin—sarcoma	0.0018	0.0018	CcSEcCtD
Degarelix—Rash—Thiotepa—sarcoma	0.0018	0.0018	CcSEcCtD
Degarelix—Dermatitis—Thiotepa—sarcoma	0.0018	0.0018	CcSEcCtD
Degarelix—Headache—Thiotepa—sarcoma	0.00179	0.00179	CcSEcCtD
Degarelix—Rash—Dactinomycin—sarcoma	0.00179	0.00179	CcSEcCtD
Degarelix—Decreased appetite—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Degarelix—Renal failure—Epirubicin—sarcoma	0.00177	0.00177	CcSEcCtD
Degarelix—Gastrointestinal disorder—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Degarelix—Asthenia—Mitoxantrone—sarcoma	0.00177	0.00177	CcSEcCtD
Degarelix—Fatigue—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Degarelix—Pain—Etoposide—sarcoma	0.00175	0.00175	CcSEcCtD
Degarelix—Constipation—Etoposide—sarcoma	0.00175	0.00175	CcSEcCtD
Degarelix—Urinary tract infection—Epirubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Degarelix—Dysuria—Doxorubicin—sarcoma	0.00175	0.00175	CcSEcCtD
Degarelix—Diarrhoea—Vincristine—sarcoma	0.00173	0.00173	CcSEcCtD
Degarelix—Pollakiuria—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Degarelix—Hepatobiliary disease—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Degarelix—Weight increased—Doxorubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Degarelix—Nausea—Thiotepa—sarcoma	0.0017	0.0017	CcSEcCtD
Degarelix—Weight decreased—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Degarelix—Feeling abnormal—Etoposide—sarcoma	0.00169	0.00169	CcSEcCtD
Degarelix—Hyperglycaemia—Doxorubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Degarelix—Diarrhoea—Mitoxantrone—sarcoma	0.00169	0.00169	CcSEcCtD
Degarelix—Nausea—Dactinomycin—sarcoma	0.00168	0.00168	CcSEcCtD
Degarelix—Gastrointestinal pain—Etoposide—sarcoma	0.00168	0.00168	CcSEcCtD
Degarelix—Dizziness—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Degarelix—Renal failure—Doxorubicin—sarcoma	0.00164	0.00164	CcSEcCtD
Degarelix—Urticaria—Etoposide—sarcoma	0.00163	0.00163	CcSEcCtD
Degarelix—Abdominal pain—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Degarelix—Body temperature increased—Etoposide—sarcoma	0.00162	0.00162	CcSEcCtD
Degarelix—Urinary tract infection—Doxorubicin—sarcoma	0.00162	0.00162	CcSEcCtD
Degarelix—Hypoaesthesia—Epirubicin—sarcoma	0.00161	0.00161	CcSEcCtD
Degarelix—Vomiting—Vincristine—sarcoma	0.00161	0.00161	CcSEcCtD
Degarelix—Urinary tract disorder—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Degarelix—Rash—Vincristine—sarcoma	0.0016	0.0016	CcSEcCtD
Degarelix—Dermatitis—Vincristine—sarcoma	0.00159	0.00159	CcSEcCtD
Degarelix—Oedema peripheral—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Degarelix—Urethral disorder—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Degarelix—Headache—Vincristine—sarcoma	0.00159	0.00159	CcSEcCtD
Degarelix—Hepatobiliary disease—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Degarelix—Vomiting—Mitoxantrone—sarcoma	0.00157	0.00157	CcSEcCtD
Degarelix—Rash—Mitoxantrone—sarcoma	0.00155	0.00155	CcSEcCtD
Degarelix—Dermatitis—Mitoxantrone—sarcoma	0.00155	0.00155	CcSEcCtD
Degarelix—Headache—Mitoxantrone—sarcoma	0.00154	0.00154	CcSEcCtD
Degarelix—Eye disorder—Epirubicin—sarcoma	0.00151	0.00151	CcSEcCtD
Degarelix—Hypersensitivity—Etoposide—sarcoma	0.00151	0.00151	CcSEcCtD
Degarelix—Nausea—Vincristine—sarcoma	0.0015	0.0015	CcSEcCtD
Degarelix—Cardiac disorder—Epirubicin—sarcoma	0.0015	0.0015	CcSEcCtD
Degarelix—Hypoaesthesia—Doxorubicin—sarcoma	0.00149	0.00149	CcSEcCtD
Degarelix—Urinary tract disorder—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Degarelix—Oedema peripheral—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Degarelix—Asthenia—Etoposide—sarcoma	0.00147	0.00147	CcSEcCtD
Degarelix—Angiopathy—Epirubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Degarelix—Urethral disorder—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Degarelix—Nausea—Mitoxantrone—sarcoma	0.00146	0.00146	CcSEcCtD
Degarelix—Immune system disorder—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Degarelix—Mediastinal disorder—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Degarelix—Chills—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Degarelix—Pruritus—Etoposide—sarcoma	0.00145	0.00145	CcSEcCtD
Degarelix—Arrhythmia—Epirubicin—sarcoma	0.00145	0.00145	CcSEcCtD
Degarelix—Alopecia—Epirubicin—sarcoma	0.00143	0.00143	CcSEcCtD
Degarelix—Mental disorder—Epirubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Degarelix—Erythema—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Degarelix—Malnutrition—Epirubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Degarelix—Diarrhoea—Etoposide—sarcoma	0.0014	0.0014	CcSEcCtD
Degarelix—Eye disorder—Doxorubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Degarelix—Cardiac disorder—Doxorubicin—sarcoma	0.00139	0.00139	CcSEcCtD
Degarelix—Back pain—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Degarelix—Angiopathy—Doxorubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Degarelix—Dizziness—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Degarelix—Muscle spasms—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Degarelix—Immune system disorder—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Degarelix—Mediastinal disorder—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Degarelix—Chills—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Degarelix—Arrhythmia—Doxorubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Degarelix—Vision blurred—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Degarelix—Alopecia—Doxorubicin—sarcoma	0.00132	0.00132	CcSEcCtD
Degarelix—Mental disorder—Doxorubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Degarelix—Ill-defined disorder—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Degarelix—Vomiting—Etoposide—sarcoma	0.0013	0.0013	CcSEcCtD
Degarelix—Malnutrition—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Degarelix—Erythema—Doxorubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Degarelix—Anaemia—Epirubicin—sarcoma	0.0013	0.0013	CcSEcCtD
Degarelix—Rash—Etoposide—sarcoma	0.00129	0.00129	CcSEcCtD
Degarelix—Dermatitis—Etoposide—sarcoma	0.00129	0.00129	CcSEcCtD
Degarelix—Headache—Etoposide—sarcoma	0.00128	0.00128	CcSEcCtD
Degarelix—Malaise—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Degarelix—Back pain—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Degarelix—Muscle spasms—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Degarelix—Palpitations—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Degarelix—Vision blurred—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Degarelix—Nausea—Etoposide—sarcoma	0.00122	0.00122	CcSEcCtD
Degarelix—Hypertension—Epirubicin—sarcoma	0.00122	0.00122	CcSEcCtD
Degarelix—Ill-defined disorder—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Degarelix—Anaemia—Doxorubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Degarelix—Arthralgia—Epirubicin—sarcoma	0.0012	0.0012	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Degarelix—Discomfort—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Degarelix—Malaise—Doxorubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Degarelix—Dry mouth—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Degarelix—Palpitations—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Degarelix—Anaphylactic shock—Epirubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Degarelix—Nervous system disorder—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Degarelix—Hypertension—Doxorubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Degarelix—Skin disorder—Epirubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Degarelix—Hyperhidrosis—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Degarelix—Arthralgia—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Degarelix—Discomfort—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Degarelix—Dry mouth—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Degarelix—Hypotension—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Degarelix—Anaphylactic shock—Doxorubicin—sarcoma	0.00106	0.00106	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Degarelix—Nervous system disorder—Doxorubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Degarelix—Insomnia—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Degarelix—Skin disorder—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Degarelix—Hyperhidrosis—Doxorubicin—sarcoma	0.00103	0.00103	CcSEcCtD
Degarelix—Dyspnoea—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Degarelix—Decreased appetite—Epirubicin—sarcoma	0.000999	0.000999	CcSEcCtD
Degarelix—Hypotension—Doxorubicin—sarcoma	0.000994	0.000994	CcSEcCtD
Degarelix—Gastrointestinal disorder—Epirubicin—sarcoma	0.000992	0.000992	CcSEcCtD
Degarelix—Fatigue—Epirubicin—sarcoma	0.000991	0.000991	CcSEcCtD
Degarelix—Pain—Epirubicin—sarcoma	0.000983	0.000983	CcSEcCtD
Degarelix—Constipation—Epirubicin—sarcoma	0.000983	0.000983	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000969	0.000969	CcSEcCtD
Degarelix—Insomnia—Doxorubicin—sarcoma	0.000962	0.000962	CcSEcCtD
Degarelix—Dyspnoea—Doxorubicin—sarcoma	0.000948	0.000948	CcSEcCtD
Degarelix—Feeling abnormal—Epirubicin—sarcoma	0.000947	0.000947	CcSEcCtD
Degarelix—Gastrointestinal pain—Epirubicin—sarcoma	0.00094	0.00094	CcSEcCtD
Degarelix—Decreased appetite—Doxorubicin—sarcoma	0.000924	0.000924	CcSEcCtD
Degarelix—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000918	0.000918	CcSEcCtD
Degarelix—Fatigue—Doxorubicin—sarcoma	0.000917	0.000917	CcSEcCtD
Degarelix—Urticaria—Epirubicin—sarcoma	0.000913	0.000913	CcSEcCtD
Degarelix—Pain—Doxorubicin—sarcoma	0.000909	0.000909	CcSEcCtD
Degarelix—Constipation—Doxorubicin—sarcoma	0.000909	0.000909	CcSEcCtD
Degarelix—Body temperature increased—Epirubicin—sarcoma	0.000909	0.000909	CcSEcCtD
Degarelix—Abdominal pain—Epirubicin—sarcoma	0.000909	0.000909	CcSEcCtD
Degarelix—Feeling abnormal—Doxorubicin—sarcoma	0.000876	0.000876	CcSEcCtD
Degarelix—Gastrointestinal pain—Doxorubicin—sarcoma	0.00087	0.00087	CcSEcCtD
Degarelix—Hypersensitivity—Epirubicin—sarcoma	0.000847	0.000847	CcSEcCtD
Degarelix—Urticaria—Doxorubicin—sarcoma	0.000845	0.000845	CcSEcCtD
Degarelix—Body temperature increased—Doxorubicin—sarcoma	0.000841	0.000841	CcSEcCtD
Degarelix—Abdominal pain—Doxorubicin—sarcoma	0.000841	0.000841	CcSEcCtD
Degarelix—Asthenia—Epirubicin—sarcoma	0.000825	0.000825	CcSEcCtD
Degarelix—Pruritus—Epirubicin—sarcoma	0.000813	0.000813	CcSEcCtD
Degarelix—Diarrhoea—Epirubicin—sarcoma	0.000786	0.000786	CcSEcCtD
Degarelix—Hypersensitivity—Doxorubicin—sarcoma	0.000784	0.000784	CcSEcCtD
Degarelix—Asthenia—Doxorubicin—sarcoma	0.000763	0.000763	CcSEcCtD
Degarelix—Dizziness—Epirubicin—sarcoma	0.00076	0.00076	CcSEcCtD
Degarelix—Pruritus—Doxorubicin—sarcoma	0.000752	0.000752	CcSEcCtD
Degarelix—Vomiting—Epirubicin—sarcoma	0.000731	0.000731	CcSEcCtD
Degarelix—Diarrhoea—Doxorubicin—sarcoma	0.000728	0.000728	CcSEcCtD
Degarelix—Rash—Epirubicin—sarcoma	0.000725	0.000725	CcSEcCtD
Degarelix—Dermatitis—Epirubicin—sarcoma	0.000724	0.000724	CcSEcCtD
Degarelix—Headache—Epirubicin—sarcoma	0.00072	0.00072	CcSEcCtD
Degarelix—Dizziness—Doxorubicin—sarcoma	0.000703	0.000703	CcSEcCtD
Degarelix—Nausea—Epirubicin—sarcoma	0.000683	0.000683	CcSEcCtD
Degarelix—Vomiting—Doxorubicin—sarcoma	0.000676	0.000676	CcSEcCtD
Degarelix—Rash—Doxorubicin—sarcoma	0.000671	0.000671	CcSEcCtD
Degarelix—Dermatitis—Doxorubicin—sarcoma	0.00067	0.00067	CcSEcCtD
Degarelix—Headache—Doxorubicin—sarcoma	0.000666	0.000666	CcSEcCtD
Degarelix—Nausea—Doxorubicin—sarcoma	0.000632	0.000632	CcSEcCtD
